These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
607 related items for PubMed ID: 18646551
1. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. III. Influence of CYP genetic polymorphism on population differentiation of drug metabolism phenotype. Tomaszewski P, Kubiak-Tomaszewska G, Łukaszkiewicz J, Pachecka J. Acta Pol Pharm; 2008; 65(3):319-29. PubMed ID: 18646551 [Abstract] [Full Text] [Related]
2. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Zhou SF, Liu JP, Chowbay B. Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967 [Abstract] [Full Text] [Related]
3. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. II. Participation of CYP isoenzymes in the metabolism of endogenous substances and drugs. Tomaszewski P, Kubiak-Tomaszewska G, Pachecka J. Acta Pol Pharm; 2008; 65(3):307-18. PubMed ID: 18646550 [Abstract] [Full Text] [Related]
4. Cytochromes P450: decision-making tools for personalized therapeutics. Murray M, Petrovic N. Curr Opin Mol Ther; 2006 Dec; 8(6):480-6. PubMed ID: 17243482 [Abstract] [Full Text] [Related]
11. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Lynch T, Price A. Am Fam Physician; 2007 Aug 01; 76(3):391-6. PubMed ID: 17708140 [Abstract] [Full Text] [Related]
12. Cytochrome P450 pharmacogenetics and cancer. Rodriguez-Antona C, Ingelman-Sundberg M. Oncogene; 2006 Mar 13; 25(11):1679-91. PubMed ID: 16550168 [Abstract] [Full Text] [Related]
13. Role of CYP pharmacogenetics and drug-drug interactions in the efficacy and safety of atypical and other antipsychotic agents. Murray M. J Pharm Pharmacol; 2006 Jul 13; 58(7):871-85. PubMed ID: 16805946 [Abstract] [Full Text] [Related]
15. Cytochrome P450-mediated metabolism in the human gut wall. Thelen K, Dressman JB. J Pharm Pharmacol; 2009 May 13; 61(5):541-58. PubMed ID: 19405992 [Abstract] [Full Text] [Related]
16. [Current availability of genetic information of drug metabolizing enzymes, particularly on cytochrome P450(CYP)]. Yamazoe Y, Nagata K. Nihon Rinsho; 2001 Aug 13; 59(8):1614-23. PubMed ID: 11519169 [Abstract] [Full Text] [Related]
18. Current cellular assays for measuring clinical drug metabolizing capacity--impact of new molecular biologic techniques. Kouri RE, McLemore T, Jaiswal AK, Nebert DW. Prog Clin Biol Res; 1986 Aug 13; 214():453-69. PubMed ID: 3523516 [No Abstract] [Full Text] [Related]
19. Bioequivalence revisited: influence of age and sex on CYP enzymes. Bebia Z, Buch SC, Wilson JW, Frye RF, Romkes M, Cecchetti A, Chaves-Gnecco D, Branch RA. Clin Pharmacol Ther; 2004 Dec 13; 76(6):618-27. PubMed ID: 15592333 [Abstract] [Full Text] [Related]
20. Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics. Johnson AD, Wang D, Sadee W. Pharmacol Ther; 2005 Apr 13; 106(1):19-38. PubMed ID: 15781120 [Abstract] [Full Text] [Related] Page: [Next] [New Search]